K M Alektiar

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 63:202-8. 2005
  2. ncbi request reprint Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 68:458-64. 2007
  3. pmc Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival
    Sewit Teckie
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Radiat Oncol 8:36. 2013
  4. ncbi request reprint Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 54:79-85. 2002
  5. ncbi request reprint Outcome of primary soft tissue sarcoma of the knee and elbow
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 54:163-9. 2002
  6. ncbi request reprint Intravaginal brachytherapy alone for intermediate-risk endometrial cancer
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:111-7. 2005
  7. ncbi request reprint When and how should adjuvant radiation be used in early endometrial cancer?
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Radiat Oncol 16:158-63. 2006
  8. doi request reprint Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 26:3440-4. 2008
  9. doi request reprint Local control comparison of adjuvant brachytherapy to intensity-modulated radiotherapy in primary high-grade sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:3229-34. 2011
  10. ncbi request reprint The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 95:316-21. 2002

Detail Information

Publications53

  1. ncbi request reprint Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 63:202-8. 2005
    ....
  2. ncbi request reprint Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 68:458-64. 2007
    ..To report preliminary results on using intensity modulated radiation therapy (IMRT) as an adjuvant treatment in primary soft tissue sarcoma (STS) of the extremity...
  3. pmc Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival
    Sewit Teckie
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Radiat Oncol 8:36. 2013
    ..Brain metastases (BM) and leptomeningeal disease (LMD) are uncommon in epithelial ovarian cancer (EOC). We investigate the outcomes of modern radiation therapy (RT) as a primary treatment modality in patients with EOC BM and LMD...
  4. ncbi request reprint Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 54:79-85. 2002
    ..The purpose of this study was to compare the outcome between PS/CC and endometrioid International Federation of Gynecology and Obstetrics (FIGO) Grade 3 cancer and was limited to patients with Stage I-II uterine carcinoma...
  5. ncbi request reprint Outcome of primary soft tissue sarcoma of the knee and elbow
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 54:163-9. 2002
    ..The purpose of this study was to determine the outcome in terms of relapse and potential complications in patients with knee and elbow soft tissue sarcoma treated with limb-sparing surgery with or without adjuvant radiotherapy (RT)...
  6. ncbi request reprint Intravaginal brachytherapy alone for intermediate-risk endometrial cancer
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:111-7. 2005
    ....
  7. ncbi request reprint When and how should adjuvant radiation be used in early endometrial cancer?
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Radiat Oncol 16:158-63. 2006
    ..If we were to use the current prevailing approach in endometrial cancer for rectal cancer, patients would still be treated with surgery alone...
  8. doi request reprint Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 26:3440-4. 2008
    ..The purpose of this study is to determine if such concern is warranted in soft-tissue sarcoma (STS) of the extremity...
  9. doi request reprint Local control comparison of adjuvant brachytherapy to intensity-modulated radiotherapy in primary high-grade sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:3229-34. 2011
    ..In recent years, intensity-modulated radiotherapy IMRT had been increasingly used. This study compared local control by IMRT versus by BRT in primary-extremity STS...
  10. ncbi request reprint The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 95:316-21. 2002
    ..The objective of this study was to determine whether the depth of myometrial invasion is correlated with outcome in patients with Stage IB endometrial carcinoma...
  11. ncbi request reprint Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 53:707-13. 2002
    ..To evaluate the outcome of patients with Stage IB Grades 1 and 2 endometrial cancer treated with adjuvant high-dose-rate intravaginal brachytherapy...
  12. ncbi request reprint High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 48:219-26. 2000
    ..This is an update of our preliminary report with longer follow-up and larger patient numbers...
  13. ncbi request reprint Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 48:1051-8. 2000
    ..The purpose of this study was to determine if adjuvant RT improves local control in patients with high-grade STS who had positive margins of resection...
  14. ncbi request reprint Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 9:48-56. 2002
    ..We reviewed single-institution experience using brachytherapy alone for primary high-grade soft tissue sarcoma of the extremity...
  15. ncbi request reprint Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:1643-50. 2002
    ..This study sought to define the optimal management in patients with stage II-B (high-grade, size < or = 5 cm) tumors...
  16. ncbi request reprint Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1273-9. 2000
    ..The purpose of this study was to evaluate the toxicity associated with adjuvant BRT in terms of wound complications, bone fracture, and peripheral nerve damage...
  17. doi request reprint Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer
    M M Leitao
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 129:38-41. 2013
    ..To determine whether the frequency of cases diagnosed with stage IIIC endometrial cancer is affected by the incorporation of a modified surgical lymph node assessment...
  18. doi request reprint Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery
    V Andikyan
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Gynecol Oncol 125:404-8. 2012
    ..To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies...
  19. doi request reprint Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes
    F Khoury-Collado
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, NY, NY 10065, USA
    Gynecol Oncol 122:251-4. 2011
    ..non-sentinel nodes in patients who had lymphatic mapping for endometrial cancer and to determine the contribution of metastases detected on ultrastaging to the overall nodal metastasis rate...
  20. ncbi request reprint Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study
    Mika A Sovak
    Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 103:451-7. 2006
    ..To determine overall survival and progression-free survival among patients with high-risk, stage III and IV endometrial cancer who receive paclitaxel and carboplatin (TC) after complete tumor resection...
  21. doi request reprint Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer
    S A Milgrom
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 130:49-53. 2013
    ..This revision may reduce rates of obtaining cytology, with unclear implications in advanced disease. This study evaluates the significance of positive cytology in stage III (FIGO 2009) endometrial cancer...
  22. doi request reprint A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care
    N R Abu-Rustum
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 116:399-403. 2010
    ..Our objective was to develop a clinically useful nomogram in the hope of providing a more individualized and accurate estimation of overall survival (OS) following primary therapy...
  23. doi request reprint Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy
    Oren Cahlon
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 112:2774-9. 2008
    ....
  24. doi request reprint Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion
    Victoria J Croog
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 111:49-54. 2008
    ..To determine the impact of the decrease in use of postoperative pelvic external beam radiation (EBRT) in favor of intravaginal RT (IVRT) alone in patients with early stage endometrial cancer who had lymphovascular invasion (LVI)...
  25. ncbi request reprint Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers
    M L Gemignani
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 50:687-94. 2001
    ..To determine the outcome for patients with recurrent gynecologic tumors treated with radical resection and combined high-dose intraoperative radiation therapy (HDR-IORT)...
  26. doi request reprint A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma
    Vicky Makker
    Memorial Sloan Kettering Cancer Center Department of Medicine, Gynecologic Medical Oncology Service, New York, NY, USA
    Gynecol Oncol 111:249-54. 2008
    ..To determine the progression-free survival (PFS) and overall survival (OS) in a cohort of patients who received either platinum-based chemotherapy with or without radiation therapy (pelvic or WAI), or RT alone...
  27. ncbi request reprint Is endometrial carcinoma intrinsically more aggressive in elderly patients?
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 98:2368-77. 2003
    ..The current study was conducted to determine the influence of old age (age >/= 70 years) on outcome in a group of patients with endometrial carcinoma who were treated with simple hysterectomy followed by adjuvant radiation therapy (RT)...
  28. doi request reprint Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh
    Andreas Rimner
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 115:149-57. 2009
    ..The authors sought to determine whether differences existed in patterns of outcome and morbidity between the 3 thigh compartments after limb-sparing surgery and postoperative radiation therapy (RT)...
  29. doi request reprint The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes
    Nadeem R Abu-Rustum
    Memorial Sloan Kettering Cancer Centerm, 1275 York Ave, NY, NY 10065, USA
    Gynecol Oncol 115:236-8. 2009
    ..To describe the incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes...
  30. doi request reprint Sarcomas across the age spectrum
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Radiat Oncol 20:45-51. 2010
    ..The other 2 are synovial sarcoma, which can be looked at as a bridge between pediatric and adult sarcomas as it affects mainly young adults, and liposarcoma that is almost exclusively an adult sarcoma...
  31. pmc Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?
    Rebecca A Gladdy
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 1209, New York, NY 10065, USA
    J Clin Oncol 28:2064-9. 2010
    ..DSS in patients with primary RAS is significantly worse compared with sporadic STS independent of sarcoma histologic type...
  32. doi request reprint Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy
    Oliver Zivanovic
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Gynecol Oncol 111:265-70. 2008
    ..The treatment of FIGO stage IB2 cervical cancer is controversial. Our aim was to assess treatment patterns, outcomes, and complications in patients with stage IB2 cervical cancer...
  33. pmc Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 112:142-5. 2009
    ..To report a single institution experience in surgical stage I-II serous endometrial cancer using combined carboplatin/paclitaxel and intravaginal radiation (IVRT)...
  34. doi request reprint Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?
    Nadeem R Abu-Rustum
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Obstet Gynecol 198:457.e1-5; discussion 457.e5-6. 2008
    ..The objective of the study was to evaluate whether surgical removal of regional lymph nodes influences the overall survival of women with endometrial carcinoma...
  35. doi request reprint What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
    Nadeem R Abu-Rustum
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 111:46-8. 2008
    ..To describe the incidence of isolated paraaortic nodal recurrences in patients with a final diagnosis of grade 1 endometrial carcinoma initially treated with surgery...
  36. ncbi request reprint Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy
    Margo Shoup
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Dis Colon Rectum 45:585-92. 2002
    ..This study was designed to determine predictors of survival after surgery and intraoperative radiotherapy for recurrent rectal cancer...
  37. ncbi request reprint Tolerance of tissue transfers to adjuvant radiation therapy in primary soft tissue sarcoma of the extremity
    Marnee M Spierer
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 56:1112-6. 2003
    ..EBRT (17% vs. 0%, p = 0.06); upper vs. lower extremity (0% vs. 8%, p = 0.41); <or=5 cm vs. >5 cm (8% vs. 4%, p = 0.9); comorbidity vs. no comorbidity (3% vs. 13%, p = 0.8); age <or=50 vs. >50 (8% vs. 4%, p = 0.8)...
  38. ncbi request reprint Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh
    Linda Hong
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 59:752-9. 2004
    ..We report the dosimetric feasibility of intensity- modulated radiation therapy (IMRT) techniques to achieve adequate target coverage and bone sparing...
  39. ncbi request reprint Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas
    Fritz C Eilber
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 12:228-36. 2005
    ..Factors prognostic for survival in patients with locally recurrent extremity soft tissue sarcomas (STS) are poorly defined, thus making it difficult to identify high-risk patients who may benefit from adjuvant therapy...
  40. ncbi request reprint Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences
    Robert A Soslow
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 31:979-87. 2007
    ....
  41. ncbi request reprint Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches
    Richard R Barakat
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Gynecol Oncol 105:150-6. 2007
    ..The purpose of this study was to analyze the results of these changes...
  42. ncbi request reprint Treatment-plan optimization for soft-tissue sarcoma brachytherapy using a genetic algorithm
    A Y Fung
    Department of Medical Physics Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1385-95. 2000
    ..To describe a treatment-plan optimization system for temporary implant of soft-tissue sarcomas using a genetic algorithm, and evaluate its potential advantages over manual planning...
  43. ncbi request reprint Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery
    A Caceres
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Gynecol Cancer 18:1139-44. 2008
    ..At a median follow-up of 26 months (range, 5-84 months), ten patients (71%) are alive and four patients (29%) have died of disease at 8, 13, 33, and 42 months postoperatively...
  44. ncbi request reprint Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era
    Trang H La
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 64:544-50. 2006
    ..To evaluate the outcomes of patients with Ewing's sarcoma family of tumors (ESFT) treated with modern radiotherapy techniques with MRI along with optimal chemotherapy...
  45. doi request reprint Local changes in bone marrow at MRI after treatment of extremity soft tissue sarcoma
    Sinchun Hwang
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
    Skeletal Radiol 38:11-9. 2009
    ..To determine the prevalence and appearance of magnetic resonance imaging (MRI) signal changes that occur in local bone marrow after radiation therapy (RT) and/or chemotherapy for extremity soft tissue sarcoma (STS)...
  46. doi request reprint Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer
    Nadeem R Abu-Rustum
    Memorial Sloan Kettering Cancer Center, Department of Surgery, Gynecology Service, New York, NY, USA
    Gynecol Oncol 111:261-4. 2008
    ..To describe the surgical and pathologic findings of fertility-sparing radical abdominal trachelectomy using a standardized surgical technique, and report the rate of post-trachelectomy adjuvant therapy that results in permanent sterility...
  47. ncbi request reprint Surgical resection of recurrent endometrial carcinoma
    Christopher S Awtrey
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, NY 10021, USA
    Gynecol Oncol 102:480-8. 2006
    ..The objective of this study was to review our experience with non-exenterative surgery for recurrent endometrial cancer...
  48. ncbi request reprint Intensity-modulated radiotherapy
    Steven A Leibel
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer J 8:164-76. 2002
    ..The implementation of biologic evaluation of tumor sensitivity, in addition to methods that improve target delineation and dose delivery, represents a new dimension in intensity-modulated radiotherapy research...
  49. ncbi request reprint Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease
    M H Einstein
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Gynecol Cancer 18:1065-70. 2008
    ..Patients who undergo completion surgery with restaging and are not upstaged appear to have a good prognosis. Surgical staging is valuable for prognosis and may alter postoperative treatments...
  50. ncbi request reprint Colorectal cancer pelvic recurrences: determinants of resectability
    Harvey G Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Dis Colon Rectum 47:1599-606. 2004
    ....
  51. ncbi request reprint Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Point
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Brachytherapy 1:191-2. 2002
  52. ncbi request reprint Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies
    Susannah M Mourton
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, NY 10021, USA
    Gynecol Oncol 100:533-6. 2006
    ..To determine the incidence and prognostic implications of positive mesorectal lymph nodes in patients undergoing total pelvic exenteration for recurrent gynecologic malignancies...
  53. ncbi request reprint Outcome of split-thickness skin grafts after external beam radiotherapy
    Duc T Bui
    Plastic and Reconstructive Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Plast Surg 52:551-6; discussion 557. 2004
    ..Minor skin graft loss resulting from postoperative radiotherapy can usually be treated conservatively without the need for additional surgery...